KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in IntangiblesChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Change in Inventory: 2018-2025

Historic Change in Inventory for BioNTech SE (BNTX) over the last 7 years, with Sep 2025 value amounting to $6.0 million.

  • BioNTech SE's Change in Inventory fell 85.33% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.6 million, marking a year-over-year decrease of 27.45%. This contributed to the annual value of $79.6 million for FY2024, which is 9.66% down from last year.
  • BioNTech SE's Change in Inventory amounted to $6.0 million in Q3 2025, which was down 76.90% from $25.8 million recorded in Q2 2025.
  • BioNTech SE's Change in Inventory's 5-year high stood at $97.7 million during Q2 2022, with a 5-year trough of -$388.3 million in Q3 2021.
  • For the 3-year period, BioNTech SE's Change in Inventory averaged around $21.5 million, with its median value being $21.3 million (2024).
  • Its Change in Inventory has fluctuated over the past 5 years, first plummeted by 212,329,753.22% in 2021, then surged by 352.19% in 2025.
  • BioNTech SE's Change in Inventory (Quarterly) stood at -$124.8 million in 2021, then dropped by 18.37% to -$147.7 million in 2022, then soared by 142.24% to $62.4 million in 2023, then slumped by 65.92% to $21.3 million in 2024, then tumbled by 85.33% to $6.0 million in 2025.
  • Its Change in Inventory was $6.0 million in Q3 2025, compared to $25.8 million in Q2 2025 and $35.6 million in Q1 2025.